What controls myelin production in the brain?
April 3, 2017The loss of myelin in the brain and spinal cord is a characteristic of MS. Myelin is a protein layer or sheath that coats and protects cells in the brain…read more
All News
Use of Gadolinium in MRI scans for MS
April 3, 2017Gadolinium is a chemical that is known as a ‘contrast agent’, meaning that it shows up in X-rays and other imaging techniques.read more
Doctors back unconventional treatment for multiple sclerosis
March 27, 2017On the ABC News 7-30 Report recently, the MS Research Australia Chief Executive Officer, Dr Matthew Miles, featured in a report discussing the approach to the management of MS founded…read more
The importance of early treatment in MS
March 27, 2017Experts in Europe recently held a debate and discussion at the European Parliament with an audience of critical stakeholders about the importance of early diagnoses and access to treatment in…read more
A blood test to distinguish between MS subtypes
March 6, 2017MS Research Australia is proud to have supported the work of Professor Gilles Guillemin and Dr Edwin Lim. Their latest work has hit the media headlines with 1 million views…read more
New funding for repair and regeneration of myelin
March 6, 2017MS results from the damage and loss of myelin, the conductive layer around nerve fibres in the brain and spinal cord. Myelin can be repaired following attacks of MS, but…read more
Is your treatment working? Perhaps your genes can tell
March 6, 2017In the past decade, several treatments for MS have become available. Many of these target cells in the immune system. However, determining which treatment would be best for everyone with…read more
MS, the immune system and a sneaky intruder
March 6, 2017Australian immunological researchers have a strong tradition of being on the cutting edge - 20 years ago, Australian Professor Peter Doherty AC was awarded the Nobel Prize in Medicine for…read more
Big-data analysis shows not all MS treatments are equal
March 6, 2017A large international study led by Dr Tomas Kalincik of The University of Melbourne together with the global MSBase Consortium has shown that the treatments alemtuzumab (Lemtrada) and natalizumab (Tysabri)…read more
First blood biomarker for multiple sclerosis discovered
February 7, 2017A blood test for determining the subtype of MS could be as little as two years away following the discovery of a blood biomarkerread more
Anxiety levels may affect thinking abilities in MS
February 1, 2017The physical effects of MS, for example on walking, are the ones that the broader community are most aware of as being a part of MS.read more
Research into lifestyle benefits for people with MS
February 1, 2017There is a great deal of interest in the MS community and reported in the media about the influence of lifestyle factors affecting MS disease course and outcomes.read more
International attention focussed on progressive MS
February 1, 2017One of the core goals of the International Progressive MS Alliance is to not only bring together researchers and fund research into progressive MS, but also to focus the attention…read more
Ageing myelin, the cause of MS?
December 10, 2016You are not as old as you think you are! We often think that our bodies are static, that it is the same body we have always had, maybe a…read more
New study shows benefits of current treatments for people with advanced MS
December 10, 2016Contrary to the notion that current treatments only benefit early stage MS, new research has shown that taking treatments that modify the immune system can improve the disease course even…read more
Heavy metals in MS
December 10, 2016In a new study published recently, tissue from the MS Research Australia Brain Bank was used. Led by Associate Professor Roger Pamphlett from the University of Sydney, to study the…read more
Smoking increases the risk of MS progression
December 10, 2016A new study by Dr Cullen O’Gorman and Professor Simon Broadley of Gold Coast Hospital and Griffith University in Queensland, has shown that secondary progressive MS can develop, on average,…read more
New plant-derived substance shows promise as a new therapy option for MS
December 10, 2016New research has just been released which has shown that a new plant derived compound can delay and reduce MS symptoms in an animal model of MS. Natural products continue…read more
Living at a higher latitude linked to earlier age of onset in MS
December 10, 2016The ‘latitude effect’ for developing MS, has long been recognised for some time, where the latitude at which a person lives can influence their overall risk of developing MS. This…read more
Non-gluten wheat sensitivity may be linked to autoimmunity
November 21, 2016Some people with MS have described finding benefit in switching to a gluten free diet, however, there is no strong scientific evidence that gluten contributes to the risk of developing…read more